Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$499,066
+$366,821 QoQ
Shares Held
71,705
+161.9% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MANGROVE PARTNERS IM, LLC holds $8,511,685 across 25 Biotechnology names. RLMD ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,916 | $916,040 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
47,927 | $868,916 | |
| 3 | ALT |
Altimmune, Inc.
|
239,280 | $736,982 | |
| 4 | ARVN |
Arvinas, Inc.
|
69,260 | $734,156 | |
| 5 | FBRX |
Forte Biosciences, Inc.
|
25,706 | $665,785 | |
| 6 | TECH |
BIO-TECHNE Corp
|
10,243 | $535,299 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
This page
|
71,705 | $499,066 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
5,531 | $371,849 |
All Filings in RLMD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $499,066 | 71,705 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $132,245 | 27,380 | Shares | Sole | 2026-02-17 | |
| 2022-03-31 | $6,965,957 | 258,094 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,998,607 | 133,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,171,793 | 159,168 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,503,701 | 46,976 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||